Containing COVID-19 with vaccines: How are we doing and what more can be done?
This event is in the past.
RSVP is closed.
The Wayne State University School of Medicine Office of Faculty Affairs & Professional Development welcomes all members of our community to join us for a Special Interactive Discussion:
"Containing COVID-19 with vaccines: How are we doing and what more can be done?"
- Identify and describe current COVID-19 trends and disease burden
- Identify and describe approved COVID-19 vaccines and other vaccines in development pipeline
- Describe opportunities and tools for addressing vaccine hesitancy in the community
Dr. Kilgore and Dr. Zervos have worked with the Mayor's office and Detroit Health Department on a variety of issues including: expanding testing capacity, mobile testing, control of COVID-19 in vulnerable populations including nursing homes, homeless shelters and participation with the health department in investigations.
Paul Kilgore, M.P.H., M.D., is an Associate Professor and Director of research at Wayne State University's College of Pharmacy & Health Sciences. He has over 25 years-experience working in medicine, public health and areas where infectious diseases thrive. He is the author of the book "The COVID-19 Survival Guide" which provides a breakdown of how the coronavirus may affect us and what we can do to successfully fight this killer virus. Dr. Kilgore recently spoke on Detroit Today about how to keep safe during the holidays. He is also the principal investigator at Henry Ford Health System's novel coronavirus vaccine trial.
Marcus Zervos, M.D., is Division Head, Infectious Diseases, Henry Ford Health System in Detroit,Michigan. He is also Assistant Dean, Global Affairs and Professor of Medicine at Wayne State University. His work has included working with vulnerable populations here and internationally. Internationally he has worked in over thirty low and middle income countries building sustainable capacity in a variety of platforms. His work locally has included water safety and legionnaires disease in Flint, and more recently COVID work in Detroit. He was appointed advisor to Mayor office for COVID-19 in March of last year.
His research has included leading the site for the Johson and Johnson vaccine and Moderna vaccine studies. He currenlty is leading the site for vaccine minority enrollment and the testing of various new therapies for COVID-19, evaluation of its epidemiology and risk factors and outcomes in affected patients.
This activity has been approved for AMA PRA Category 1 Credit™